Kavita Kongara, MD
Gastroenterology · Atlanta, GANPI 1952370959
Payments from drug & device makers
Across 760 payments — averaging $646.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ardelyx, Inc.$152K
- Phathom Pharmaceuticals, Inc.$139K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$116K
- AbbVie$73K
- Ironwood Pharmaceuticals, Inc$3K
- Sanofi$3K
- plus $6K from 31 others
What the payments were for
- Consulting fees$110,80123%
- Speaking & faculty fees$310,82563%
- Travel & lodging$51,76211%
- Food & beverage$18,2744%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ardelyx, Inc. | 129 | $151,637 |
| Phathom Pharmaceuticals, Inc. | 121 | $138,861 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 161 | $116,279 |
| AbbVie(2 entities) | 175 | $73,292 |
| Ironwood Pharmaceuticals, Inc | 12 | $3,007 |
| Sanofi | 7 | $2,557 |
| Bausch Health US, LLC | 2 | $2,010 |
| Mahana Therapeutics, Inc. | 1 | $1,000 |
| Takeda Pharmaceuticals U.S.A., Inc. | 42 | $715 |
| Johnson & Johnson | 34 | $562 |
| Merck | 8 | $268 |
| QOL Medical, LLC | 8 | $172 |
| Lilly USA, LLC | 7 | $167 |
| Boston Scientific | 7 | $167 |
| Bristol Myers Squibb | 9 | $157 |
| Daiichi Sankyo Inc. | 5 | $97 |
| Regeneron Healthcare Solutions, Inc. | 3 | $83 |
| Celltrion USA Inc. | 3 | $74 |
| Ipsen Biopharmaceuticals, Inc | 3 | $66 |
| Ferring Pharmaceuticals Inc. | 3 | $58 |
| Madrigal Pharmaceuticals | 2 | $52 |
| Amgen | 2 | $51 |
| Sanofi-aventis U.S. LLC | 1 | $36 |
| Medtronic | 1 | $32 |
| Alfasigma USA, Inc. | 2 | $28 |
| Pfizer | 1 | $25 |
| Sandoz | 1 | $24 |
| Romark Laboratories, LC | 1 | $23 |
| Organon | 1 | $22 |
| Novo Nordisk | 1 | $22 |
| Shire North American Group Inc | 1 | $20 |
| Vivus LLC | 1 | $19 |
| Nestle Healthcare Nutrition Inc. | 1 | $18 |
| Aimmune Therapeutics, Inc. | 1 | $18 |
| Lumendi LLC | 1 | $15 |
| UCB, Inc. | 1 | $14 |
| AstraZeneca | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$491,662 in reported general payments places this provider in the 95th percentile of 492 gastroenterology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IbsrelaTenapanor Hcl | 23 | $56,971 |
| LinzessLinaclotide | 24 | $23,076 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 85 | $5,545 |
| Dexlansoprazole DrDexlansoprazole | 12 | $4,833 |
| Colesevelam Hcl | 20 | $2,301 |
| Lubiprostone | 17 | $2,044 |
| Pantoprazole Sodium | 113 | $1,157 |
| Omeprazole | 75 | $948 |
| Famotidine | 47 | $536 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 32 | $477 |
| Lactulose | 29 | $341 |
| Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg | 13 | $266 |
| Ondansetron OdtOndansetron | 21 | $140 |
| Lansoprazole | 11 | $104 |
| Ondansetron Hcl | 54 | $52 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Ardelyx, Inc.Ibsrela | $151,637 | $56,97123 claims |
| AbbVieLinzess | $73,292 | $23,07624 claims |
| SandozLansoprazole | $24 | $10411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 492 gastroenterology providers in Georgia.
Other gastroenterology in Atlanta
- Douglas WolfAtlanta$6.4M
- Michael GalambosAtlanta$1.8M
- Nitin GuptaAtlanta$1.7M
- Heba IskandarAtlanta$978K
- Cynthia RudertAtlanta$720K
- Girish AnandAtlanta$425K
- Julia LiuAtlanta$412K
- Norman GitlinAtlanta$399K
- Saul KarpenAtlanta$368K
- Roshan ShresthaAtlanta$323K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.